7210 Wareham Drive, Tampa, FL 33647
August 4, 2022 Medifast reported its Q2 2022 results. Management reported that: “We delivered another solid quarter at Medifast, with revenues up 15%, almost 15% growth in the number of active earning Coaches, and robust Coach productivity. The customized support of OPTAVIA Coaches remains a key differentiator for our business, and these results are a demonstration […]
Medifast Reports Q2 Results, Stock Price Sinks Read More »
May 2, 2022 “Record quarterly revenues, sharp acceleration in coach metrics and an increase in our annual financial guidance are powerful indications of the underlying strength of our business. We have record numbers of independent active earning OPTAVIA Coaches, helping us drive robust product demand and rapidly increasing digital engagement, and bolstering OPTAVIA to the #1 revenue
Medifast Reports 1st Quarter 2022 Results Read More »
May 6, 2021 Medifast reported results for the first quarter ended March 31, 2021. “This has been an exceptional quarter of growth and productivity, reflecting the outstanding abilities of both our independent OPTAVIA Coaches and our employees,” said Dan Chard, Chairman and Chief Executive Officer of Medifast. “We now have a record 52,500 OPTAVIA Coaches who are achieving new
Medifast Reports Q1 2021 Results – On Track For $1.4 Billion In Sales Read More »
Dec. 29, 2020 “Our business continues to go from strength to strength, with high levels of client demand and engagement among independent OPTAVIA Coaches, accelerated growth and record levels of active earning Coaches,” said Dan Chard, CEO of Medifast. “Our programming efforts this year, along with enhancements to our organization, have given us a foundation for significant
Medifast Reports Q3 Results Read More »
Nov. 7, 2018 — 3rd Quarter 2018 Highlights: Revenue of $139.2 million, an increase of 80.3% year-over-year Active earning Coaches of 22,600, an increase of 59.2% year-over-year Net income of $13.8 million, an increase of 106.1% year-over-year Earnings per diluted share (“EPS”) of $1.14, an increase of 107.3% year-over-year Dan Chard, Medifast’s CEO, said: …”We are
Medifast Reports Q3 Results – Stock Gets Crushed Read More »